Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Baxter vs Seto and Co..

<< Previous

Bullboard Posts

Next >>

Comment by hmmmmmmmmon Feb 02, 2023 10:42pm

217 Views

Post# 35263935

RE:RE:Baxter vs Seto and Co..

Baxter "purchasing of notes" was just fronting money from the interim milestone payment. Needing to beg for that is in no way a sign of strength on Spectral's end.

No 180 in sentiment. Management issues on DIMI trial/ loss of control of DIMI, Tigris trial enrollment numbers, and basic disclosure/ transparency. Those giant things you keep trying to say don't matter.

But you keep shilling for management and your Aberta insiders group- and I'll keep reminding you of the facts.

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China